Prudential Financial Inc Neurocrine Biosciences Inc Transaction History

Prudential Financial Inc

  • $67.5 Billion
  • Q1 2025

A detailed history of Prudential Financial Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Prudential Financial Inc holds 119,300 shares of NBIX stock, worth $15.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
119,300
Previous 210,175 43.24%
Holding current value
$15.1 Million
Previous $28.7 Million 54.01%
% of portfolio
0.02%
Previous 0.04%

Shares

37 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
SELL
$107.22 - $153.29 $9.74 Million - $13.9 Million
-90,875 Reduced 43.24%
119,300 $13.2 Million
Q4 2024

Feb 11, 2025
BUY
$111.62 - $139.44 $3.73 Million - $4.66 Million
33,450 Added 18.93%
210,175 $28.7 Million
Q3 2024

Nov 13, 2024
SELL
$114.58 - $153.15 $2.01 Million - $2.68 Million
-17,529 Reduced 9.02%
176,725 $20.3 Million
Q2 2024

Aug 13, 2024
BUY
$130.86 - $143.19 $10.2 Million - $11.2 Million
78,136 Added 67.29%
194,254 $26.7 Million
Q1 2024

May 14, 2024
SELL
$130.4 - $143.74 $27.8 Million - $30.7 Million
-213,253 Reduced 64.75%
116,118 $16 Million
Q4 2023

Feb 13, 2024
BUY
$106.07 - $132.76 $5.33 Million - $6.67 Million
50,204 Added 17.98%
329,371 $43.4 Million
Q3 2023

Nov 13, 2023
BUY
$94.02 - $117.1 $18.2 Million - $22.6 Million
193,117 Added 224.42%
279,167 $31.4 Million
Q2 2023

Aug 11, 2023
BUY
$89.53 - $104.87 $1.97 Million - $2.31 Million
21,980 Added 34.31%
86,050 $8.11 Million
Q1 2023

May 12, 2023
BUY
$94.11 - $123.02 $865,153 - $1.13 Million
9,193 Added 16.75%
64,070 $6.49 Million
Q4 2022

Feb 14, 2023
BUY
$106.72 - $127.06 $557,825 - $664,142
5,227 Added 10.53%
54,877 $0
Q3 2022

Nov 04, 2022
BUY
$92.03 - $107.81 $1.84 Million - $2.16 Million
19,991 Added 67.4%
49,650 $5.15 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $2.36 Million - $3.12 Million
-31,192 Reduced 51.26%
29,659 $2.91 Million
Q1 2022

May 13, 2022
BUY
$72.45 - $94.81 $2.82 Million - $3.69 Million
38,962 Added 178.0%
60,851 $5.71 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $326,246 - $435,077
4,096 Added 23.02%
21,889 $2.03 Million
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $476,575 - $547,635
-5,530 Reduced 23.71%
17,793 $1.72 Million
Q2 2021

Aug 16, 2021
SELL
$89.43 - $102.27 $1.36 Million - $1.56 Million
-15,208 Reduced 39.47%
23,323 $2.27 Million
Q1 2021

May 12, 2021
SELL
$87.57 - $119.4 $2.45 Million - $3.35 Million
-28,016 Reduced 42.1%
38,531 $3.75 Million
Q4 2020

Feb 16, 2021
BUY
$86.91 - $108.33 $5.58 Million - $6.95 Million
64,186 Added 2718.59%
66,547 $6.38 Million
Q3 2020

Aug 05, 2021
SELL
$96.16 - $135.15 $7.25 Million - $10.2 Million
-75,381 Reduced 96.96%
2,361 $227,000
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $7.27 Million - $10.2 Million
75,655 Added 3625.06%
77,742 $7.48 Million
Q2 2020

Aug 05, 2021
SELL
$85.09 - $130.36 $7.44 Million - $11.4 Million
-87,456 Reduced 97.67%
2,087 $255,000
Q2 2020

Aug 12, 2020
BUY
$85.09 - $130.36 $7.46 Million - $11.4 Million
87,649 Added 4627.72%
89,543 $10.9 Million
Q1 2020

Aug 05, 2021
SELL
$75.11 - $113.76 $3.93 Million - $5.95 Million
-52,269 Reduced 96.5%
1,894 $164,000
Q1 2020

May 12, 2020
BUY
$75.11 - $113.76 $3.96 Million - $6 Million
52,750 Added 3733.19%
54,163 $4.69 Million
Q4 2019

Aug 05, 2021
SELL
$86.8 - $118.57 $3.7 Million - $5.05 Million
-42,618 Reduced 96.79%
1,413 $152,000
Q4 2019

Feb 11, 2020
BUY
$86.8 - $118.57 $3.7 Million - $5.05 Million
42,627 Added 3036.11%
44,031 $4.73 Million
Q3 2019

Aug 05, 2021
SELL
$83.82 - $101.5 $3.48 Million - $4.21 Million
-41,466 Reduced 96.72%
1,404 $127,000
Q3 2019

Nov 13, 2019
BUY
$83.82 - $101.5 $3.49 Million - $4.22 Million
41,618 Added 3324.12%
42,870 $3.86 Million
Q2 2019

Aug 05, 2021
SELL
$72.24 - $91.27 $506,980 - $640,532
-7,018 Reduced 84.86%
1,252 $106,000
Q2 2019

Aug 08, 2019
BUY
$72.24 - $91.27 $510,447 - $644,913
7,066 Added 586.88%
8,270 $0
Q1 2019

Aug 05, 2021
SELL
$69.31 - $91.53 $784,311 - $1.04 Million
-11,316 Reduced 90.38%
1,204 $106,000
Q1 2019

May 15, 2019
BUY
$69.31 - $91.53 $843,294 - $1.11 Million
12,167 Added 3446.74%
12,520 $0
Q4 2018

Aug 05, 2021
SELL
$68.32 - $124.36 $1.76 Million - $3.2 Million
-25,767 Reduced 98.65%
353 $25,000
Q4 2018

Feb 07, 2019
SELL
$68.32 - $124.36 $23,228 - $42,282
-340 Reduced 1.28%
26,120 $1.87 Million
Q3 2018

Nov 07, 2018
BUY
$98.88 - $125.85 $2.16 Million - $2.75 Million
21,890 Added 478.99%
26,460 $0
Q4 2017

Feb 13, 2018
SELL
$58.53 - $77.59 $40,971 - $54,313
-700 Reduced 13.28%
4,570 $355,000
Q3 2017

Nov 02, 2017
BUY
$47.97 - $61.28 $252,801 - $322,945
5,270
5,270 $323,000

Others Institutions Holding NBIX

# of Institutions
649
Shares Held
97.1M
Call Options Held
749K
Put Options Held
553K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email